Chinese brain-computer interface startup NeuroXess raises RMB 700 million in Series B funding

The round was co-led by SDIC Juli, Shenzhen Capital Group and Qinzhi Capital. NeuroXess develops implantable systems with flexible electrodes and wireless power and data transmission, designed to support movement and speech decoding and control of external devices. The company says it has completed 65 clinical cases and launched a registration trial involving nearly 20 hospitals in July. It is building a 14,300-square-meter facility with planned annual capacity of 10,000 systems.